SCHEMBL16658679

SCHEMBL16658679

CCCCCCCCCCCCCCCCN(C)C(C)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 5/20 0.50
EPHX2 P34913 5/20 0.47
S1PR2 O95136 1/20 0.44
S1PR1 P21453 1/20 0.44
S1PR3 Q99500 1/20 0.44
S1PR5 Q9H228 1/20 0.44
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
GGPS1 O95749 3/20 0.41
GPR84 Q9NQS5 2/20 0.41
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
TLR2 O60603 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9387264 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL4601205 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL16658724 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL18660081 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL16658678 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL6949703 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL3440790 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL1902069 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL2180094 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3
SCHEMBL2485136 1.00 DNM1 (0.50) DNM1EPHX2S1PR2S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9199948-B2 1,3-benzoxazol-2(3H)-ones and their use as medicaments and cosmetics DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-12-01 US disclosed
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS TRPV1, TRPA1, P2RX3 DNM1 3867/4885EPHX2 816/4885S1PR2 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.